3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2004240563 (hide)

Owner Merck & Co., Inc.

Inventors Feng, Danqing Dennis; Qian, Xiaoxia; Liang, Gui-Bai; Biftu, Tesfaye

Agent Spruson & Ferguson

Pub. Number AU-A-2004240563

PCT Pub. Number WO2004/103276

Priority 60/470,564 14.05.03 US

Filing date 10 May 2004

Wipo publication date 2 December 2004

International Classifications

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/103276 Priority application(s): WO2004/103276

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240565-Smoking article and smoking article filter

2004240561-A transgenic animal model for cancer and stem cells